SCN10A and peripheral neuropathy: Our results indicate that a Nav1.8 blocker should reduce spontaneous firing which supports the role of Nav1.8 in contributing to the increased excitability in peripheral neuropathy (Xiao et al., 2019; Zhang et al., 2019).